Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AR-12286 in Glaucoma Patients With Uncontrolled IOP
NCT02174991Phase 2Unknown
- Sponsor
- New York Glaucoma Research Institute
- Start
- Jun 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verosudil in open-angle glaucoma (OAG), sponsored by New York Glaucoma Research Institute. Status: unknown.
02
Drugs
verosudil
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT02174991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02174991.